TMDX - TransMedics Group Stock: Too Far Too Fast
2024-07-08 13:15:38 ET
Summary
- TransMedics Group, Inc. provides technology for organ transplants throughout the United States. The stock has more than tripled since late October.
- The company delivered blowout Q1 results, but the stock's valuation has become more than dear.
- Can the rally continue, or are TransMedics Group shares overdue for some profit taking? An analysis follows in the paragraphs below.
Today, we are putting TransMedics Group, Inc. ( TMDX ) in the spotlight. This company provides the technology needed to transform/enable organ transplant therapy for end-stage organ failure patients. The company's stock has more than tripled since the summer market swoon ended in late October. Can the good times continue for shareholders? An updated analysis follows below....
TransMedics Group Stock: Too Far, Too Fast